Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Cost of Revenue (2017 - 2025)

Inspire Medical Systems' Cost of Revenue history spans 9 years, with the latest figure at $36.1 million for Q4 2025.

  • For Q4 2025, Cost of Revenue changed 0.23% year-over-year to $36.1 million; the TTM value through Dec 2025 reached $133.2 million, up 8.33%, while the annual FY2025 figure was $133.2 million, 8.33% up from the prior year.
  • Cost of Revenue for Q4 2025 was $36.1 million at Inspire Medical Systems, up from $31.8 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $36.1 million in Q4 2025 and bottomed at $6.0 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $24.3 million (2023), against an average of $22.6 million.
  • The largest annual shift saw Cost of Revenue soared 284.75% in 2021 before it dropped 1.93% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $11.2 million in 2021, then skyrocketed by 98.57% to $22.2 million in 2022, then grew by 26.64% to $28.1 million in 2023, then increased by 28.28% to $36.0 million in 2024, then increased by 0.23% to $36.1 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Cost of Revenue are $36.1 million (Q4 2025), $31.8 million (Q3 2025), and $34.7 million (Q2 2025).